Table 5.

Number of prevented strokes and costs per prevented stroke in each intervention group.

Study arm, CHA2DS2-VASc scorea		Cost difference for all patientsb (in €c)	Prevented strokes	Costs per prevented stroke (in €)	Prevented fatal strokes	Costs per prevented fatal stroke (in €)
Study arm with device (100% ECGd confirmation)
	1	12,519,300	53	236,213	5	2,503,860
	2	17,893,200	–26	–688,200	–47	–380,706
	3	15,759,300	154	102,333	51	309,006
	4	16,852,500	366	46,045	232	72,640
	5	19,992,600	545	36,684	401	49,857
	6	21,174,300	848	24,970	669	31,651
	7	18,103,800	1101	16,443	848	21,349
	8	23,481,300	1363	17,228	1073	21,884
	9	34,921,800	1355	25,773	1308	26,699
Study arm with device (75% ECG confirmation)
	1	13,228,200	25	529,128	7	1,889,743
	2	17,028,300	–68	–250,416	–54	–315,339
	3	16,074,000	98	164,020	–5	–3,214,800
	4	15,609,900	266	58,684	182	85,769
	5	18,181,800	364	49,950	271	67,092
	6	18,732,600	642	29,179	440	42,574
	7	18,676,800	722	25,868	599	31,180
	8	20,762,700	1111	18,688	815	25,476
	9	25,423,200	1116	22,781	928	27,396
Study arm with device (50% ECG confirmation)
	1	13,704,000	–18	–761,333	5	2,740,800
	2	15,242,700	–13	–1,172,515	–71	–214,686
	3	13,933,500	33	422,227	–18	–774,083
	4	11,367,300	357	31,841	169	67,262
	5	10,708,500	371	28,864	96	111,547
	6	17,187,900	234	73,453	176	97,659
	7	11,712,000	567	20,656	400	29,280
	8	18,208,800	446	40,827	324	56,200
	9	23,614,500	364	64,875	384	61,496

^aCHA₂DS₂-VASc: Congestive heart failure, Hypertension, Age≥75 years, Diabetes mellitus, Stroke, Vascular disease, Age 65-74 years, Sex category (female).

^bCost difference between group with devices and group without devices.

^c€1=US $1.12.

^dECG: electrocardiography.